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Brucellosis is a zoonotic infection of worldwide distribution
caused by Brucella spp, small coccoid aerobic, oxidase-posi-
tive, Gram-negative rods.1 Human cases are usually infected
by consumption of unpasteurized dairy products, in particular
raw goat cheese or milk. The incubation period of brucellosis
may be prolonged, 2 months or longer, and the clinical pre-
sentation is characterized by a long-lasting febrile illness,
frequently accompanied by focal manifestations.2 We present
herein a case of brucellar mastitis and give a review of cases
published in the literature during the last 30 years.3—9
A 33-year-old pregnant Iraqi female with a 25-week gesta-
tion presented in June 2006 at Ulleva˚l University Hospital,
Oslo, with a six-day history of fever, moderate constitutional
symptoms, and pain in both breasts. The patient, who had
lived in Norway since 1996, had visited friends and relatives
in Iraqi Kurdistan from June 2005 to April 2006. When
admitted, she did not appear seriously ill, had a temperature
of 37.9 8C and a heart pulse of 125 beats per minute. Both
breasts exhibited painful peri-areolar erythema and moder-
ate diffuse swellings, but no fluctuation was palpable. There
was a lymphadenitis in the left axilla. A mammary ultrasound
detected bilateral edema, compatible with mastitis. Serum
C-reactive protein was 66 mg/l (normal range 0—10 mg/l),
hemoglobin 10.2 g/dl (11.7—15.3 g/dl), and the erythrocyte
sedimentation rate 64 mm/h (3—20 mm/h). As staphylococ-
cal infection was suspected, the patient was treated empiri-
cally with cloxacillin and clindamycin, however there was no
clinical improvement. A second mammary ultrasound per-
formed 4 days later detected changes consistent with pus-
dilated ducts and a conglomerate of abscesses in the right
breast (Figure 1), from which pus was aspirated. A few days
later, similar findings also appeared in the left breast. Bac-
teriologic examination of pus and blood cultures revealed
growth of a small Gram-negative, oxidase-positive rod. The
isolate was later identified as Brucella spp by sequencing a
470-bp fragment of the 16S rRNA gene.10 The sequence
showed 100% homology with the gene of Brucella melitensis,
Brucella abortus, and Brucella suis, as identified using the
GenBank online service. Susceptibility testing (E-test, AB
Biodisk, Solna, Sweden) on brucella agar gave the following
minimum inhibitory concentrations (MICs): rifampin
0.016 mg/l, doxycycline 0.06 mg/l, and streptomycin
2 mg/l. Trimethoprim—sulfamethoxazole (TMP/SMX) tested1201-9712/$32.00 # 2007 International Society for Infectious Diseases.on Mueller—Hinton agar with 5% horse blood gave a MIC of
0.25 mg/l. An ELISA performed on serum drawn 16 days after
symptom onset was consistent with recent brucellosis (Bru-
cella IgG 1040 and Brucella IgM 1100). The patient was
diagnosed with bilateral brucellar mastitis and concurrent
bacteremia. Treatment was changed to PO rifampin 900 mg
od and PO TMP/SMX 160 mg/800 mg bid, and the patient was
discharged. She later completed a 6-week course and made a
full recovery. When seen for follow-up, the patient related
that she had consumed goat milk while in Iraq.
A Medline search performed in July 2006 identified seven
additional cases of brucellar mastitis published in the litera-
ture since the 1970s;3—9 a summary of pertinent epidemio-
logical and clinical data for all eight patients is provided in
Table 1. With the exception of the present case, which was
imported to Norway from Iraq, and one case imported to
Germany from Portugal,4 all patients presented in countries
where brucellosis is endemic. Also, with the exception of the
current case, the German case,4 and one case of laboratory-
acquired infection,7 all patients lived in rural areas where
there was animal breeding. In four of the eight cases, a
predisposing factor of mastitis could be identified, including
pregnancy, recurrent mastitis, and breast implants. The time
lag from symptom onset to diagnosis ranged from 1 week to
several months. Four patients had bilateral mastitis, and six
of the eight patients had developed breast abscesses at the
time of diagnosis. Spontaneous perforation occurred in two
patients. Three patients had palpable axillary lymphadenitis,
and three had concurrent bacteremia. Culture of pus
sampled by fine needle aspiration identified Brucella spp
in six cases; identification in infected tissue was made by
surgical biopsy in two cases. Brucella serology, in most cases
performed using the agglutination test, was compatible with
recent infection in all cases. There was no consistency of the
choice of antibiotic therapy, and also the duration of treat-
ment varied extensively, from 6 weeks to 12 months. Three
patients were treated surgically; in two cases due to sus-
pected malignancy3,4 and in one case with removal of breast
implants.7 All patients were cured.
Brucellosis is often complicated by hematogenous spread
to various organs and may present with focal manifestations,
most commonly in the osteoarticular, urogenital, or central
nervous systems.2 In contrast to many animal species, in
which Brucella has a viscerotropism for the mammary glands,
humans rarely acquire brucellar mastitis. The incidence,
however, may be underestimated, and the high frequencyPublished by Elsevier Ltd. All rights reserved.
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Table 1 Published cases of brucellar mastitis, 1991—2007
Age/country of
disease
acquisition
Predisposing
condition
Time lag from
symptom onset
to diagnosis
Localization Abscess
formation
Diagnostic
procedure
Isolated
bacteria
Concurrent
bacteremia
Brucella
serology
Antibiotic
therapy
Surgery Outcome Reference
No./year of
publication
52/Spain None ND Bilateral Yes;
multiple
Surgical biopsy B. melitensis
type 1
No Positive Doxycycline 9 w +
streptomycin 6 w
Abscess
extirpation
Cured 3/1991
46/Portugal None 10 days Left breast None Surgical biopsy ND No Positive Tetracycline 6 w +
streptomycin 2 w
Tumor
extirpation
Cured 4/1991
39/Saudi Arabia None 2 weeks Left breast Yes;
single
Fine needle
aspiration
B. melitensis ND Positive Doxycycline 3 mo +
TMP/SMX 3 mo
None Cured 5/1996
32/Turkey Pregnancy 4 months Bilateral Yes;
multiple
Fine needle
aspiration
B. melitensis No Positive TMP/SMX 2 w +
ceftriaxone 5 w;
followed by
doxycycline 4 mo +
rifampin 4 mo
postpartum
None Cured 6/1999
48/Saudi Arabia Breast
implants
2 months Bilateral None Puss sampling B. melitensis Yes Positive Doxycycline 10 mo +
rifampin 10 mo
Bilateral
capsulectomy
Cured 7/2001
77/Greece Recurrent
mastitis
3 weeks Left breast Yes;
multiple
Fine needle
aspiration
B. melitensis Yes Positive Doxycycline 8 w +
streptomycin 3 w
None Cured 8/2003
63/Turkey None 1 month Left breast Yes;
single
Fine needle
aspiration
Brucella spp No Positive Tetracycline 1 y +
rifampin 1 y
None Cured 9/2006
33/Iraq Pregnancy 1 week Bilateral Yes;
multiple
Fine needle
aspiration
Brucella spp Yes Positive TMP/SMX 6 w +
rifampin 6 w
None Cured PC/2007
ND, no data; TMP/SMX, trimethoprim—sulfamethoxazole; PC, present case.
doi:10.1016/j.ijid.2007.03.007
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Figure 1 Ultrasonography of the patient’s right breast showing
sharply demarcated and slightly hypoechoic lesions (broad
arrows) with posterior echo enhancement (between the thin
arrows), consistent with abscess.of abscess formation in the present review is likely to reflect
an unfortunate diagnostic delay in some cases. Brucellosis
may be difficult to diagnose due to non-specific presentation
and possible misinterpretation of in vitro diagnostic
tests,11,12 but as shown here, brucellar mammary infection
can be diagnosed by a combination of serology and fine-
needle aspiration or tissue biopsy for culture.
In contrast to staphylococcal mastitis, the most common
form of breast infection in humans, the present literature
review shows that brucellar mastitis is not primarily seen in
lactating women. This is in parallel with other forms of
human mastitis assumed to be secondary to hematogenous
spread, including those caused by fungi, Gram-negative bac-
teria, and mycobacteria.13
With the exception of the patient with breast implants and
the two patients in whom malignancy was suspected, all
published cases of brucellar mastitis were treated conserva-
tively. The standard treatment for uncomplicated brucellosis,
as proposed by theWorld HealthOrganization in 1986, consists
of doxycycline plus either an aminoglycoside or rifampin given
for 6 weeks.2 In pregnant women there has been no consensus
with regard to the best therapeutic regimen, but a combina-
tion of rifampin andTMP/SMX for 4—6weeksappears tobe safe
and efficacious,14 andwas used in our casewith good results. It
shouldbeconsideredmandatory to treatpregnantwomenwith
brucellosis urgently, since infection in gestation poses a sub-
stantial risk of spontaneous abortion.
Although an oddity, brucellar mastitis should serve as a
reminder that brucellosis can affect virtually any organ or
organ system of the body, and should be considered a differ-
ential diagnosis in any unclear febrile disease in a person
living in or returning from endemic areas. This is especially
true when there is a history of consumption of unpasteurized
dairy products.
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